Winfred Seth Gbewonyo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Winfred Seth Gbewonyo has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Boison
Department of Biochemistry, School of Biological Sciences, University of Cape Coast, Cape Coast, Ghana
1 shared publication Ibrahim Luru Abdulai
West African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, P.O. Box LG 54, Legon, Accra, Ghana
1 shared publication- Joshua Buer Puplampu
Department of Biochemistry, School of Biological Sciences, University of Cape Coast, Cape Coast, Ghana
1 shared publication - Michael Buenor Adinortey
Department of Biochemistry, School of Biological Sciences, University of Cape Coast, Cape Coast, Ghana
1 shared publication - Samuel Kojo Kwofie
Department of Biomedical Engineering, School of Engineering Sciences, College of Basic and Applied Sciences, University of Ghana, Legon, Accra, Ghana
1 shared publication
Latest Publications
- Open Access
- 10 April 2021
- Published by Wiley in The Scientific World Journal
- Vol. 2021, 1-20
Multitargeted Effects of Vitexin and Isovitexin on Diabetes Mellitus and Its Complications
Background. Till date, there is no known antidote to cure diabetes mellitus despite the discovery and development of diverse pharmacotherapeutic agents many years ago. Technological advancement in natural product chemistry has led to the isolation of analogs of vitexin and isovitexin found in diverse bioresources. These compounds have been extensively studied to explore their pharmacological relevance in diabetes mellitus. Aim of the Study. The present review was to compile results from in vitro and in vivo studies performed with vitexin and isovitexin derivatives relating to diabetes mellitus and its complications. A systematic online literature query was executed to collect all relevant articles published up to March 2020. Results. In this piece, we have collected data and presented it in a one-stop document to support the multitargeted mechanistic actions of vitexin and isovitexin in controlling diabetes mellitus and its complications. Conclusion. Data collected hint that vitexin and isovitexin work by targeting diverse pathophysiological and metabolic pathways and molecular drug points involved in the clinical manifestations of diabetes mellitus. This is expected to provide a deeper understanding of its actions and also serve as a catapult for clinical trials and application research.
- 10 April 2021
- Published by Wiley in The Scientific World Journal
- Vol. 2021, 1-20
Open AccessMultitargeted Effects of Vitexin and Isovitexin on Diabetes Mellitus and Its Complications
Background. Till date, there is no known antidote to cure diabetes mellitus despite the discovery and development of diverse pharmacotherapeutic agents many years ago. Technological advancement in natural product chemistry has led to the isolation of analogs of vitexin and isovitexin found in diverse bioresources. These compounds have been extensively studied to explore their pharmacological relevance in diabetes mellitus. Aim of the Study. The present review was to compile results from in vitro and in vivo studies performed with vitexin and isovitexin derivatives relating to diabetes mellitus and its complications. A systematic online literature query was executed to collect all relevant articles published up to March 2020. Results. In this piece, we have collected data and presented it in a one-stop document to support the multitargeted mechanistic actions of vitexin and isovitexin in controlling diabetes mellitus and its complications. Conclusion. Data collected hint that vitexin and isovitexin work by targeting diverse pathophysiological and metabolic pathways and molecular drug points involved in the clinical manifestations of diabetes mellitus. This is expected to provide a deeper understanding of its actions and also serve as a catapult for clinical trials and application research.